- ATAI Life Sciences NV Announces Strategic Investment in Beckley Psytech Ltd Call TranscriptJan 04, 2024
- Q3 2022 ATAI Life Sciences NV Earnings Presentation TranscriptNov 10, 2022
- ATAI Life Sciences NV R&D Investor Day TranscriptOct 25, 2022
- ATAI Life Sciences NV at Citi BioPharma Conference TranscriptSep 07, 2022
- Q2 2022 ATAI Life Sciences NV Earnings Presentation TranscriptAug 15, 2022
- ATAI Life Sciences NV at Citi Biopharma Co-Panel Day (Virtual) TranscriptMay 18, 2022
- Q1 2022 ATAI Life Sciences NV Earnings Call TranscriptMay 16, 2022€3.46 (-1.99%)Earnings
- Q4 2021 ATAI Life Sciences NV Earnings Call TranscriptMar 30, 2022€4.82 (+7.59%)Earnings
- ATAI Life Sciences NV at Citi Winter Biotech Virtual Bus Tour TranscriptMar 22, 2022
- Atai Life Sciences N.V. - Special Call TranscriptJan 18, 2022
- Q3 2021 ATAI Life Sciences NV Earnings Call TranscriptNov 15, 2021€11.36 (-11.66%)Earnings
- ATAI Life Sciences NV at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 11, 2021
- ATAI Life Sciences NV at Citi BioPharma Conference (Virtual) TranscriptSep 08, 2021
ATAI Life Sciences NV at Citi BioPharma Conference Transcript
I'm Neena Bitritto-Garg, and I'm one of the biotech analysts here at Citi. I'm very pleased to be joined for our next company panel where we're going to be focusing on mental health and new kind of innovative options for mental health conditions. I've got with me the new CEO of COMPASS Pathways, Kabir Nath; the Chief Medical Officer of Pear Therapeutics, Yuri Maricich; and Florian Brand, the CEO of Atai Life Sciences.
So before we get into Q&A, I want to pass it to each of you to make some opening remarks. And maybe we'll start with Florian.
Sure, yes. Happy to be here. Thanks for overseeing us. And I think it's a very interesting panel as it combines a range of modalities that we, I think, all are working on, especially with the digital component. And so here is Atai, our biotech -- or biopharmaceutical company in the clinical stage and also heavily believe in the potential of digital
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)